article

Drug Target Review Antibodies ebook 2021

Posted: 31 March 2021 | | No comments yet

Within this ebook, find articles on how a lead bNAb candidate was identified to combat COVID-19 and why antibodies could present the answer to HIV treatment and vaccines. 

Antibodies are a vital part of therapeutic treatment as researchers continue to make significant developments in the biologics field, especially as monoclonal antibodies (mAbs) show great promise. 

Here, we discuss how a broadly neutralising antibody (bNAb) lead was created and selected with the potential to combat SARS-CoV-2 and results from two pre-clinical studies into how antibodies can be used as treatments and prophylactics for HIV. 

Included in this ebook:

  • Developing a broadly neutralising antibody therapeutic to combat SARS-CoV-2
    Dr Laura Walker, Adagio Therapeutics 
  • Fighting HIV: could antibodies be the answer?
    Victoria Rees, Drug Target Review 












    To read this in-depth focus in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of Agilent

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    Send this to a friend